Clorox (CLX) reported $1.67 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 8.1%. EPS of $1.45 for the same period compares to $1.71 a year ago.

The reported revenue represents a surprise of -2.67% over the Zacks Consensus Estimate of $1.71 billion. With the consensus EPS estimate being $1.57, the EPS surprise was -7.64%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Clorox performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Organic Revenue Growth - Health and Wellness: 3% compared to the -1.9% average estimate based on four analysts.
• Organic Revenue Growth - International: 2% compared to the 6% average estimate based on four analysts.
• Organic Revenue Growth - Lifestyle: -3% compared to the 0.3% average estimate based on four analysts.
• Organic Revenue Growth - Household: -11% versus the four-analyst average estimate of -1.5%.
• Organic Sales Growth: -2% versus 1.2% estimated by four analysts on average.
• Net Revenue- Health and Wellness: $630 million compared to the $597.23 million average estimate based on four analysts. The reported number represents a change of +3.5% year over year.
• Net Revenue- International: $263 million compared to the $258.40 million average estimate based on four analysts. The reported number represents a change of -15.2% year over year.
• Net Revenue- Lifestyle: $306 million versus $314.14 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -2.9% change.
• Net Revenue- Household: $469 million versus $515.48 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -10.8% change.
• Income before income taxes- Health and Wellness: $169 million versus the two-analyst average estimate of $176.17 million.
• Income before income taxes- Corporate and Other: -$55 million compared to the -$68.49 million average estimate based on two analysts.
• Income before income taxes- International: $31 million compared to the $27.86 million average estimate based on two analysts.

View all Key Company Metrics for Clorox here>>>

Shares of Clorox have returned -3.3% over the past month versus the Zacks S&P 500 composite's +0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Clorox Company (CLX) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research